STAINES-UPON-THAMES, United Kingdom, Sept. 13, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced find

Study Highlights the Utility of Bacterial Fluorescence Imaging to Provide Real-Time Information to Clinicians on a Wound's Bacterial Burden that Significantly Impacted Treatment Decisions TORONTO, Sept. 13, 2019 /PRNewswire/ - MolecuLight Inc., the world's leader in handheld real-time fluorescence imaging for chronic wounds, announces

PLEASANTON, Calif., Sept. 13, 2019 /PRNewswire/ -- Shaklee Corporation, a leading natural nutrition company, is proud to announce the induction of Samantha Achterberg and Charles Fernandez to the Shaklee Pure Performance Team, which consists of Shaklee's 80+ sponsored athletes. Achterberg and Fernandez are Mod

SEATTLE and VANCOUVER, British Columbia, Sept. 13, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that two presentations featuring final data from the Phase

HERZLIYA, Israel, Sept. 13, 2019 /PRNewswire/ -- InterCure (TASE: INCR), announced that subsidiary Canndoc has entered into a strategic distribution agreement with Salomon, Levin, Elstein (S.L.E.,) which is owned by Teva Pharmaceuticals Industries (NYSE: and TASE: TEVA). Under terms of the agreement, S.L.E. will distribute Canndoc's GMP products to pharma clients,

DENVER, Sept. 13, 2019 /PRNewswire/ -- A new, two-minute screening technique could help save cats from dying prematurely of heart disease. Morris Animal Foundation-fun

SAN DIEGO, Sept. 13, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that the global phase III FeDeriCa study conducted by Genentech, a member of the Roche Group, met its primary endpoint. The FeDeriCa study investigated a fixed-dose combination of pertuzu

INCLINE VILLAGE, Nev., Sept. 12, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has entered into separate privately negotiated transactions to exchange approximately $86.1 million in aggregate principal amount of its 2.75% Convertible Senior Notes due 2021 (the "Existing Not

LOVELAND, Colo., Sept. 12, 2019 /PRNewswire/ -- Heska Corporation (Nasdaq: HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty healthcare products, today announced the pricing of $75.0 million aggregate principal amount of convertible senior notes due 2026 (the "Notes") in a private offering (the "Offe

SALT LAKE CITY, Sept. 12, 2019 /PRNewswire/ -- Health Catalyst wrapped up its 2019